SCHEDULE 13G · 2026-11-10
State Street Corporation has filed a Schedule 13G revealing a 4.6% stake in Vera Therapeutics, indicating growing institutional interest in the pharmaceutical sector.
| Name | Vera Therapeutics, Inc. |
|---|---|
| CIK | 0001831828 |
| Tickers | VERA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 812744449 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 650-770-0077 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
State Street Corporation has filed a Schedule 13G revealing a 4.6% stake in Vera Therapeutics, indicating growing institutional interest in the pharmaceutical sector.
480 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000722 | 005-92556 | 261556489 | 34 | 7821 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-004552 | 005-92556 | 261555915 | 34 | 10726 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005080 | 005-92556 | 261555813 | 34 | 11397 | |||
| 2026-11-10 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000740 | 005-92556 | 261538390 | 34 | 8060 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-449826 | 001-40407 | 261527402 | 34 | 11580251 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-449780 | 001-40407 | 261527226 | 34 | 777288 | 1 | 1 |
| 2026-09-17 | 4 | xslF345X06/form4-09172026_080936.xml | 0001859453-26-000015 | 8787 | ||||||
| 2026-09-15 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-391280 | 001-40407 | 261379101 | 34 | 11190591 | 1 | 1 |
| 2026-09-14 | 4 | xslF345X06/form4-09142026_080921.xml | 0001861684-26-000006 | 7044 | ||||||
| 2026-09-04 | 4 | xslF345X06/form4-09042026_040901.xml | 0001859453-26-000014 | 9248 | ||||||
| 2026-09-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009028 | 001-40407 | 261355381 | 33 | 6551 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001907884-26-000015 | 005-92556 | 261278622 | 34 | 9578 | |||
| 2026-08-12 | 4/A | xslF345X06/form4a-08122026_100831.xml | 0001859453-26-000013 | 15803 | ||||||
| 2026-08-12 | 4/A | xslF345X06/form4a-08122026_100823.xml | 0001859453-26-000012 | 11306 | ||||||
| 2026-08-12 | 4/A | xslF345X06/form4a-08122026_100809.xml | 0001859453-26-000011 | 11764 | ||||||
| 2026-08-10 | 10-Q | 10-Q | 0001193125-26-342380 | 001-40407 | 261258500 | 34 | 9844826 | 1 | 1 | |
| 2026-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-342335 | 001-40407 | 261258346 | 34 | 737990 | 1 | 1 |
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000554 | 005-92556 | 261252409 | 34 | 8089 | |||
| 2026-08-05 | 4 | xslF345X06/form4-08052026_080802.xml | 0002145711-26-000002 | 7691 | ||||||
| 2026-08-05 | 3 | xslF345X06/form3-08052026_080847.xml | 0002145711-26-000001 | 9905 | ||||||
| 2026-07-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003123 | 005-92556 | 261221075 | 34 | 11125 | |||
| 2026-07-09 | 4 | xslF345X06/form4-07092026_040701.xml | 0001859453-26-000010 | 12793 | ||||||
| 2026-07-09 | 8-K | 8-K | 5.02 | 0001193125-26-299165 | 001-40407 | 261164007 | 34 | 144500 | 1 | 1 |
| 2026-07-07 | 8-K | 8-K | 8.01 | 0001193125-26-297211 | 001-40407 | 261158630 | 34 | 144062 | 1 | 1 |
| 2026-06-24 | 4 | xslF345X06/form4-06242026_080643.xml | 0001859453-26-000008 | 8379 | ||||||
| 2026-06-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006433 | 001-40407 | 261111423 | 33 | 6554 | |||
| 2026-06-02 | 8-K | 8-K | 8.01 | 0001193125-26-252475 | 001-40407 | 261053599 | 34 | 148865 | 1 | 1 |
| 2026-05-26 | 8-K | 8-K | 5.07 | 0001193125-26-239559 | 001-40407 | 261020817 | 34 | 173697 | 1 | 1 |
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080514.xml | 0001662426-26-000002 | 5884 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080555.xml | 0001778307-26-000002 | 5854 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080559.xml | 0001184592-26-000002 | 5834 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080547.xml | 0001822092-26-000005 | 5832 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080541.xml | 0001387521-26-000002 | 5849 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080529.xml | 0001897965-26-000002 | 5864 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080523.xml | 0001202096-26-000002 | 6031 | ||||||
| 2026-05-26 | 4 | xslF345X06/form4-05262026_080520.xml | 0001253886-26-000004 | 5874 | ||||||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000080255-26-000426 | 005-92556 | 26983467 | 34 | 7741 | |||
| 2026-05-13 | 4 | xslF345X06/form4-05132026_080543.xml | 0001859453-26-000007 | 8837 | ||||||
| 2026-05-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004408 | 001-40407 | 26969200 | 33 | 6302 | |||
| 2026-05-07 | 10-Q | 10-Q | 0001193125-26-212143 | 001-40407 | 26954166 | 34 | 9808351 | 1 | 1 | |
| 2026-05-07 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-210351 | 001-40407 | 26950879 | 34 | 677334 | 1 | 1 |
| 2026-04-15 | 4 | xslF345X06/form4-04152026_080434.xml | 0001859453-26-000006 | 11019 | ||||||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003436 | 001-40407 | 26861192 | 33 | 5570 | |||
| 2026-04-09 | ARS | ARS | 0001140361-26-014008 | 001-40407 | 26851633 | 34 | 5261284 | |||
| 2026-04-09 | DEFA14A | DEFA14A | 0001140361-26-014006 | 001-40407 | 26851619 | 34 | 1347188 | |||
| 2026-04-09 | DEF 14A | DEF 14A | 0001140361-26-014002 | 001-40407 | 26851605 | 34 | 6335351 | 1 | 1 | |
| 2026-04-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-001831 | 005-92556 | 26829627 | 34 | 18268 | |||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002499 | 005-92556 | 26805061 | 34 | 7168 | |||
| 2026-03-25 | 4 | xslF345X06/form4-03252026_110324.xml | 0001614568-26-000008 | 7790 | ||||||
| 2026-03-25 | 3 | xslF345X06/form3-03252026_110337.xml | 0001614568-26-000007 | 8752 | ||||||
| 2026-03-16 | 4 | xslF345X05/form4-03162026_100309.xml | 0001861684-26-000005 | 7080 | ||||||
| 2026-03-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001342 | 005-92556 | 26743257 | 34 | 11176 | |||
| 2026-03-09 | 8-K | 8-K | 5.02 | 0001193125-26-098783 | 001-40407 | 26735975 | 34 | 148483 | 1 | 1 |
| 2026-03-09 | 4 | xslF345X05/form4-03092026_080317.xml | 0001814238-26-000005 | 5431 | ||||||
| 2026-03-09 | 3 | xslF345X02/form3-03092026_080309.xml | 0001814238-26-000004 | 8220 | ||||||
| 2026-03-05 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-26-023756 | 005-92556 | 26724087 | 34 | 45673 | |||
| 2026-02-27 | S-8 | S-8 | 0001193125-26-078157 | 333-293830 | 26691604 | 33 | 227203 | 1 | 1 | |
| 2026-02-26 | 10-K | 10-K | 0001193125-26-077442 | 001-40407 | 26690649 | 34 | 27336106 | 1 | 1 | |
| 2026-02-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-073421 | 001-40407 | 26681708 | 34 | 696300 | 1 | 1 |
| 2026-02-25 | 4 | xslF345X05/form4-02262026_010204.xml | 0002006910-26-000004 | 6040 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_010213.xml | 0001861684-26-000004 | 6027 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_120222.xml | 0001872792-26-000004 | 6727 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_120224.xml | 0001859453-26-000004 | 7427 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_120221.xml | 0001733883-26-000006 | 6049 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_120218.xml | 0001819688-26-000005 | 6044 | ||||||
| 2026-02-25 | 4 | xslF345X05/form4-02262026_120224.xml | 0002108080-26-000004 | 6034 | ||||||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001670 | 001-40407 | 26665963 | 33 | 4750 | |||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001669 | 001-40407 | 26665950 | 33 | 4766 | |||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001668 | 001-40407 | 26665936 | 33 | 4751 | |||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001667 | 001-40407 | 26665918 | 33 | 4758 | |||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001661 | 001-40407 | 26665766 | 33 | 4766 | |||
| 2026-02-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001646 | 001-40407 | 26665669 | 33 | 4766 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000080255-26-000281 | 005-92556 | 26637736 | 34 | 7625 | |||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080213.xml | 0001861684-26-000002 | 7549 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080211.xml | 0001859453-26-000002 | 9461 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080209.xml | 0001872792-26-000002 | 8453 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080207.xml | 0002108080-26-000002 | 7552 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080205.xml | 0001819688-26-000002 | 7562 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080203.xml | 0001733883-26-000002 | 7841 | ||||||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_080201.xml | 0002006910-26-000002 | 7762 | ||||||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000540 | 005-92556 | 26602071 | 34 | 11477 | |||
| 2026-01-30 | 3 | 3 | 0001193125-26-031763 | 22195 | ||||||
| 2026-01-30 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000262 | 005-92556 | 26582596 | 34 | 6966 | |||
| 2025-12-18 | 8-K | 8-K | 5.02 | 0001193125-25-323298 | 001-40407 | 251580976 | 34 | 134460 | 1 | 1 |
| 2025-12-17 | 4 | 4 | 0001193125-25-322691 | 8881 | ||||||
| 2025-12-15 | 4 | 4 | 0001193125-25-319649 | 7501 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010312 | 001-40407 | 251571816 | 33 | 6240 | |||
| 2025-12-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-314430 | 001-40407 | 251562803 | 34 | 442557 | 1 | 1 |
| 2025-12-10 | 424B5 | 424B5 | 0001193125-25-314244 | 333-282861 | 251562276 | 33 | 690594 | 1 | 1 | |
| 2025-12-10 | 4 | 4 | 0001193125-25-314156 | 8881 | ||||||
| 2025-12-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-009958 | 001-40407 | 251556621 | 33 | 5509 | |||
| 2025-12-08 | 424B5 | 424B5 | 0001193125-25-311219 | 333-282861 | 251556169 | 33 | 557623 | |||
| 2025-12-04 | 4 | 4 | 0001193125-25-308074 | 8355 | ||||||
| 2025-12-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-009711 | 001-40407 | 251546883 | 33 | 4781 | |||
| 2025-11-26 | 4 | 4 | 0001193125-25-300677 | 5392 | ||||||
| 2025-11-26 | 3 | 3 | 0001193125-25-300675 | 14973 | ||||||
| 2025-11-26 | 8-K | 8-K | 5.02 | 0001193125-25-300647 | 001-40407 | 251530793 | 34 | 150582 | 1 | 1 |
| 2025-11-25 | 4 | 4 | 0001193125-25-297161 | 5055 | ||||||
| 2025-11-24 | 144 | xsl144X01/primary_doc.xml | 0001193125-25-294092 | 001-40407 | 251514874 | 33 | 4262 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000080255-25-000840 | 005-92556 | 251483448 | 34 | 7625 | |||
| 2025-11-13 | 4 | 4 | 0001193125-25-280792 | 8681 | ||||||
| 2025-11-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-268331 | 001-40407 | 251456646 | 34 | 710545 | 1 | 1 |
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-266881 | 001-40407 | 251453886 | 34 | 10681766 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-265799 | 001-40407 | 251451854 | 34 | 721760 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001085146-25-005108 | 005-92556 | 251215588 | 34 | 9314 | |||
| 2025-08-05 | 8-K | 8-K | 1.01,1.02,9.01 | 0001193125-25-173591 | 001-40407 | 251185845 | 34 | 401300 | 1 | 1 |
| 2025-08-05 | 424B5 | 424B5 | 0001193125-25-173588 | 333-282861 | 251185803 | 33 | 657862 | 1 | 1 | |
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-103022 | 001-40407 | 251184946 | 34 | 10047785 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-102399 | 001-40407 | 251182808 | 34 | 668512 | 1 | 1 |
| 2025-06-25 | 4 | 4 | 0000950170-25-090110 | 11927 | ||||||
| 2025-06-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-000870 | 005-92556 | 251041041 | 34 | 16647 | |||
| 2025-06-03 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-25-133730 | 001-40407 | 251017110 | 34 | 546702 | 1 | 1 |
| 2025-06-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-132736 | 001-40407 | 251013085 | 34 | 10661377 | 1 | 1 |
| 2025-05-19 | 8-K | 8-K | 5.07 | 0000950170-25-074446 | 001-40407 | 25964597 | 34 | 182071 | 1 | 1 |
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080547.xml | 0001415889-25-013423 | 5717 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080556.xml | 0001415889-25-013421 | 5736 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080502.xml | 0001415889-25-013420 | 5679 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080509.xml | 0001415889-25-013419 | 5893 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080516.xml | 0001415889-25-013417 | 5696 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080530.xml | 0001415889-25-013415 | 5726 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080528.xml | 0001415889-25-013412 | 5746 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_080509.xml | 0001415889-25-013408 | 5726 | ||||||
| 2025-05-07 | 10-Q | 10-Q | 0000950170-25-064733 | 001-40407 | 25918754 | 34 | 8764880 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063975 | 001-40407 | 25915296 | 34 | 681422 | 1 | 1 |
| 2025-04-03 | ARS | ARS | 0001140361-25-012039 | 001-40407 | 25809507 | 34 | 4150678 | |||
| 2025-04-03 | DEFA14A | DEFA14A | 0001140361-25-012036 | 001-40407 | 25809473 | 34 | 11269297 | |||
| 2025-04-03 | DEF 14A | DEF 14A | 0001140361-25-012034 | 001-40407 | 25809418 | 34 | 5708002 | 1 | 1 | |
| 2025-02-28 | S-8 | S-8 | 0001193125-25-042606 | 333-285445 | 25691310 | 33 | 286906 | 1 | 1 | |
| 2025-02-28 | 10-K | 10-K | 0000950170-25-029969 | 001-40407 | 25689821 | 34 | 30159256 | 1 | 1 | |
| 2025-02-27 | 4 | xslF345X05/form4-02272025_090225.xml | 0001415889-25-005841 | 10798 | ||||||
| 2025-02-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-001279 | 001-40407 | 25670401 | 33 | 7049 | |||
| 2025-02-26 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-027337 | 001-40407 | 25666214 | 34 | 386032 | 1 | 1 |
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090211.xml | 0001415889-25-004851 | 7547 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090246.xml | 0001415889-25-004849 | 7561 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090217.xml | 0001415889-25-004847 | 7764 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090254.xml | 0001415889-25-004846 | 8242 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090218.xml | 0001415889-25-004845 | 8252 | ||||||
| 2025-02-20 | 4 | xslF345X05/form4-02202025_090230.xml | 0001415889-25-004844 | 7565 | ||||||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-000985 | 005-92556 | 25623917 | 34 | 10646 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-005010 | 001-40407 | 25524909 | 34 | 10487959 | 1 | 1 |
| 2025-01-10 | 4 | xslF345X05/form4-01102025_090146.xml | 0001415889-25-001242 | 18357 | ||||||
| 2025-01-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000187 | 001-40407 | 25518794 | 33 | 9476 | |||
| 2024-12-20 | 4 | xslF345X05/form4-12202024_091238.xml | 0001415889-24-029964 | 28880 | ||||||
| 2024-12-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009959 | 001-40407 | 241559489 | 33 | 9250 | |||
| 2024-12-13 | 4 | xslF345X05/form4-12132024_091242.xml | 0001415889-24-029275 | 21811 | ||||||
| 2024-12-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009703 | 001-40407 | 241542232 | 33 | 8520 | |||
| 2024-11-27 | 4 | xslF345X05/form4-11272024_091139.xml | 0001415889-24-027840 | 26934 | ||||||
| 2024-11-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009075 | 001-40407 | 241496541 | 33 | 9254 | |||
| 2024-11-20 | 4 | xslF345X05/form4-11202024_091116.xml | 0001415889-24-027332 | 7421 | ||||||
| 2024-11-20 | 3 | xslF345X02/form3-11202024_091109.xml | 0001415889-24-027331 | 9762 | ||||||
| 2024-11-15 | 4 | xslF345X05/form4-11152024_091112.xml | 0001415889-24-026944 | 46584 | ||||||
| 2024-11-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-045861 | 005-92556 | 241462202 | 34 | 98383 | |||
| 2024-11-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-045842 | 005-92556 | 241461868 | 34 | 98196 | |||
| 2024-11-14 | SC 13G | vera13gsep24.txt | 0000080255-24-001473 | 005-92556 | 34 | 6463 | ||||
| 2024-11-14 | SC 13G/A | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-005820 | 005-92556 | 241459248 | 34 | 44239 | |||
| 2024-11-14 | SC 13G | VERA THERAPEUTICS, INC. | 0000902664-24-006527 | 005-92556 | 241457831 | 34 | 61609 | |||
| 2024-11-13 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-008508 | 001-40407 | 241454672 | 33 | 9249 | |||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002869 | 005-92556 | 241444963 | 34 | 8124 | |||
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123239 | 001-40407 | 241435341 | 34 | 8367865 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-122814 | 001-40407 | 241433260 | 34 | 312399 | 1 | 1 |
| 2024-11-04 | SC 13D/A | SC 13D/A | 0001193125-24-250796 | 005-92556 | 241425230 | 34 | 115616 | |||
| 2024-10-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-248079 | 001-40407 | 241412199 | 34 | 468432 | 1 | 1 |
| 2024-10-30 | 424B5 | 424B5 | 0001193125-24-247568 | 333-282861 | 241410533 | 33 | 903938 | |||
| 2024-10-30 | 4 | xslF345X05/form4-10302024_081020.xml | 0001415889-24-025746 | 8035 | ||||||
| 2024-10-29 | 424B5 | 424B5 | 0001193125-24-245751 | 333-282861 | 241402516 | 33 | 745807 | |||
| 2024-10-28 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-24-245704 | 001-40407 | 241402089 | 34 | 9185687 | 1 | 1 |
| 2024-10-28 | S-3ASR | S-3ASR | 0001193125-24-245701 | 333-282861 | 241402050 | 33 | 1059788 | |||
| 2024-10-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007911 | 001-40407 | 241401389 | 33 | 6905 | |||
| 2024-10-25 | 4 | xslF345X05/form4-10252024_081055.xml | 0001415889-24-025634 | 23229 | ||||||
| 2024-10-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007852 | 001-40407 | 241389426 | 33 | 8478 | |||
| 2024-10-11 | 4 | xslF345X05/form4-10112024_081019.xml | 0001415889-24-025024 | 12523 | ||||||
| 2024-10-09 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007640 | 001-40407 | 241362979 | 33 | 7753 | |||
| 2024-10-02 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-230760 | 001-40407 | 241345430 | 34 | 16565031 | 1 | 1 |
| 2024-09-27 | 4 | xslF345X05/form4-09272024_080904.xml | 0001415889-24-024033 | 50482 | ||||||
| 2024-09-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007388 | 001-40407 | 241324543 | 33 | 7025 | |||
| 2024-09-20 | 4 | xslF345X05/form4-09202024_080929.xml | 0001415889-24-023779 | 10415 | ||||||
| 2024-09-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007226 | 001-40407 | 241308016 | 33 | 4665 | |||
| 2024-09-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007224 | 001-40407 | 241308012 | 33 | 4870 | |||
| 2024-09-13 | 4 | xslF345X05/form4-09132024_080943.xml | 0001415889-24-023372 | 12521 | ||||||
| 2024-09-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-006960 | 001-40407 | 241292867 | 33 | 6533 | |||
| 2024-08-30 | 4 | xslF345X05/form4-08302024_080840.xml | 0001415889-24-022620 | 16475 | ||||||
| 2024-08-28 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-006580 | 001-40407 | 241255664 | 33 | 6161 | |||
| 2024-08-23 | 4 | xslF345X05/form4-08232024_090800.xml | 0001415889-24-022150 | 5384 | ||||||
| 2024-08-16 | 4 | xslF345X05/form4-08162024_080827.xml | 0001415889-24-021460 | 9270 | ||||||
| 2024-08-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-006014 | 001-40407 | 241208397 | 33 | 4851 | |||
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-094108 | 001-40407 | 241189083 | 34 | 8363733 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093342 | 001-40407 | 241186125 | 34 | 309856 | 1 | 1 |
| 2024-07-03 | 4 | xslF345X05/form4-07032024_080715.xml | 0001415889-24-019162 | 5513 | ||||||
| 2024-07-03 | 3 | xslF345X02/form3-07032024_080700.xml | 0001415889-24-019158 | 8722 | ||||||
| 2024-07-02 | 8-K | 8-K | 5.02,9.01 | 0001193125-24-174318 | 001-40407 | 241095137 | 34 | 453434 | 1 | 1 |
| 2024-06-12 | 8-K | 8-K | 5.02 | 0001193125-24-159935 | 001-40407 | 241038420 | 34 | 151560 | 1 | 1 |
| 2024-06-11 | 4 | xslF345X05/form4-06112024_080614.xml | 0001415889-24-016358 | 5405 | ||||||
| 2024-06-11 | 3 | xslF345X02/form3-06112024_080657.xml | 0001415889-24-016354 | 9677 | ||||||
| 2024-05-17 | 8-K | 8-K | 5.07 | 0000950170-24-061872 | 001-40407 | 24961310 | 34 | 178241 | 1 | 1 |
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080555.xml | 0001415889-24-013504 | 19053 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080552.xml | 0001415889-24-013498 | 5571 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080541.xml | 0001415889-24-013490 | 5738 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080522.xml | 0001415889-24-013478 | 5885 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080515.xml | 0001415889-24-013476 | 5714 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080545.xml | 0001415889-24-013473 | 5718 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080506.xml | 0001415889-24-013472 | 5733 | ||||||
| 2024-05-17 | 4 | xslF345X05/form4-05172024_080535.xml | 0001415889-24-013470 | 5718 | ||||||
| 2024-05-10 | 10-Q | 10-Q | 0000950170-24-057292 | 001-40407 | 24932141 | 34 | 7919863 | 1 | 1 | |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-056283 | 001-40407 | 24928584 | 34 | 286696 | 1 | 1 |
| 2024-05-03 | DEFA14A | DEFA14A | 0001193125-24-130666 | 001-40407 | 24912873 | 34 | 13616 | |||
| 2024-04-12 | 4 | xslF345X05/form4-04122024_080416.xml | 0001415889-24-010753 | 4815 | ||||||
| 2024-04-05 | 4 | xslF345X05/form4-04062024_010405.xml | 0001415889-24-010473 | 39905 | ||||||
| 2024-04-05 | 4 | xslF345X05/form4-04062024_010432.xml | 0001415889-24-010472 | 13943 | ||||||
| 2024-04-04 | ARS | ARS | 0001140361-24-017732 | 001-40407 | 24821477 | 34 | 4010628 | |||
| 2024-04-03 | DEFA14A | DEFA14A | 0001140361-24-017652 | 001-40407 | 24819836 | 34 | 3593965 | |||
| 2024-04-03 | DEF 14A | DEF 14A | 0001140361-24-017650 | 001-40407 | 24819818 | 34 | 2216951 | |||
| 2024-04-03 | 144 | xsl144X01/primary_doc.xml | 0001974078-24-000148 | 001-40407 | 24818924 | 33 | 7385 | |||
| 2024-03-27 | S-8 | S-8 | 0001193125-24-078822 | 333-278277 | 24790824 | 33 | 105448 | |||
| 2024-03-27 | 10-K | 10-K | 0000950170-24-036729 | 001-40407 | 24785485 | 34 | 17106438 | 1 | 1 | |
| 2024-03-26 | SC 13D/A | SC 13D/A | 0001104659-24-039188 | 005-92556 | 24785393 | 34 | 135328 | |||
| 2024-03-25 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-038589 | 17647 | ||||||
| 2024-03-21 | 144 | xsl144X01/primary_doc.xml | 0001968582-24-000241 | 001-40407 | 24772076 | 33 | 4475 | |||
| 2024-03-20 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-033947 | 001-40407 | 24766286 | 34 | 294573 | 1 | 1 |
| 2024-02-20 | SC 13D/A | SC 13D/A | 0001104659-24-025676 | 005-92556 | 24655775 | 34 | 131311 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023924 | 005-92556 | 24639963 | 34 | 137670 | |||
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006666 | 005-92556 | 24638150 | 34 | 98298 | |||
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006601 | 005-92556 | 24637722 | 34 | 98272 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023492 | 005-92556 | 24636741 | 34 | 141670 | |||
| 2024-02-14 | SC 13G/A | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-001352 | 005-92556 | 24635165 | 34 | 44229 | |||
| 2024-02-12 | SC 13G | p24-0709sc13g.htm | 0000902664-24-001434 | 005-92556 | 24620635 | 34 | 52214 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001585 | 005-92556 | 24612694 | 34 | 8101 | |||
| 2024-02-05 | SC 13D/A | SC 13D/A | 0001193125-24-024125 | 005-92556 | 24596441 | 34 | 117387 | |||
| 2024-02-01 | 4 | OWNERSHIP DOCUMENT | 0001104659-24-009537 | 5701 | ||||||
| 2024-01-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-019496 | 001-40407 | 24578932 | 34 | 433131 | 1 | 1 |
| 2024-01-30 | 424B5 | 424B5 | 0001193125-24-019492 | 333-265408 | 24578897 | 33 | 721219 | |||
| 2024-01-29 | S-3MEF | S-3MEF | 0001193125-24-018532 | 333-276761 | 24575602 | 33 | 55033 | |||
| 2024-01-29 | SC 13G | us92337r1014_012924.txt | 0001086364-24-005502 | 005-92556 | 24574901 | 34 | 13463 | |||
| 2024-01-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-000497 | 001-40407 | 24574068 | 33 | 4732 | |||
| 2024-01-29 | 424B5 | 424B5 | 0001193125-24-017530 | 333-265408 | 24570560 | 33 | 722857 | |||
| 2024-01-29 | 8-K | 8-K | 2.02,8.01 | 0001193125-24-017311 | 001-40407 | 24569969 | 34 | 153819 | 1 | 1 |
| 2024-01-25 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-014808 | 001-40407 | 24558504 | 34 | 19926863 | 1 | 1 |
| 2024-01-18 | 4 | xslF345X05/form4-01182024_090156.xml | 0001415889-24-001526 | 7542 | ||||||
| 2024-01-18 | 4 | xslF345X05/form4-01182024_090112.xml | 0001415889-24-001518 | 7740 | ||||||
| 2024-01-18 | 4 | xslF345X05/form4-01182024_090121.xml | 0001415889-24-001514 | 10517 | ||||||
| 2024-01-12 | 4 | xslF345X05/ownership.xml | 0001493152-24-002290 | 5815 | ||||||
| 2024-01-09 | 4 | FORM 4 SUBMISSION | 0001209191-24-001231 | 5561 | ||||||
| 2024-01-09 | 3 | FORM 3 SUBMISSION | 0001209191-24-001229 | 6888 | ||||||
| 2024-01-08 | 4 | FORM 4 SUBMISSION | 0001209191-24-001087 | 5550 | ||||||
| 2024-01-08 | 3 | FORM 3 SUBMISSION | 0001209191-24-001086 | 7267 | ||||||
| 2024-01-08 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-24-003931 | 001-40407 | 24518428 | 34 | 185049 | 1 | 1 |
| 2024-01-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-003928 | 001-40407 | 24518419 | 34 | 14157975 | 1 | 1 |
| 2024-01-03 | 4 | FORM 4 SUBMISSION | 0001209191-24-000352 | 10920 | ||||||
| 2023-12-26 | 8-K | 8-K | 2.03 | 0001193125-23-303004 | 001-40407 | 231513322 | 34 | 151119 | 1 | 1 |
| 2023-11-13 | SC 13G/A | filing.txt | 0000315066-23-002759 | 005-92556 | 231395636 | 34 | 8123 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-062139 | 001-40407 | 231393077 | 34 | 8647304 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061548 | 001-40407 | 231390125 | 34 | 355259 | 1 | 1 |
| 2023-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-047105 | 5347 | ||||||
| 2023-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-047103 | 5588 | ||||||
| 2023-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-047102 | 5589 | ||||||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-041399 | 001-40407 | 231160085 | 34 | 9809234 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-040973 | 001-40407 | 231157248 | 34 | 364766 | 1 | 1 |
| 2023-08-02 | SC 13D/A | SC 13D/A | 0001193125-23-201784 | 005-92556 | 231136748 | 34 | 198887 | |||
| 2023-07-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-041521 | 6964 | ||||||
| 2023-07-05 | SC 13D/A | SC 13D/A | 0001193125-23-181969 | 005-92556 | 231069201 | 34 | 200268 | |||
| 2023-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-23-039323 | 7356 | ||||||
| 2023-06-22 | 4 | xslF345X04/ownership.xml | 0001493152-23-022130 | 6261 | ||||||
| 2023-06-22 | 3 | xslF345X02/ownership.xml | 0001493152-23-022128 | 4784 | ||||||
| 2023-06-20 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-169612 | 001-40407 | 231023412 | 34 | 11175062 | 1 | 1 |
| 2023-05-17 | 8-K | 8-K | 5.07 | 0001193125-23-146313 | 001-40407 | 23929387 | 34 | 157788 | 1 | 1 |
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029038 | 8646 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029034 | 8972 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029031 | 8811 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029024 | 8762 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029018 | 8783 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029014 | 8809 | ||||||
| 2023-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-23-029008 | 8782 | ||||||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021335 | 001-40407 | 23911733 | 34 | 8982162 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020841 | 001-40407 | 23908835 | 34 | 345523 | 1 | 1 |
| 2023-04-13 | SC 13D/A | SC 13D/A | 0001193125-23-100524 | 005-92556 | 23818429 | 34 | 186880 | |||
| 2023-04-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-022150 | 5953 | ||||||
| 2023-03-30 | ARS | ARS | 0000950170-23-011016 | 001-40407 | 23781596 | 34 | 3627160 | |||
| 2023-03-30 | DEFA14A | DEFA14A | 0001140361-23-014836 | 001-40407 | 23781012 | 34 | 3248497 | |||
| 2023-03-30 | DEF 14A | DEF14A | 0001140361-23-014835 | 001-40407 | 23781008 | 34 | 2164778 | |||
| 2023-03-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-021609 | 5956 | ||||||
| 2023-03-28 | S-8 | S-8 | 0001193125-23-082342 | 333-270911 | 23770728 | 33 | 83149 | |||
| 2023-03-28 | 10-K | 10-K | 0000950170-23-010288 | 001-40407 | 23769704 | 34 | 15165823 | 1 | 1 | |
| 2023-03-28 | 4 | FORM 4 SUBMISSION | 0001209191-23-021386 | 8912 | ||||||
| 2023-03-28 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-010114 | 001-40407 | 23766160 | 34 | 368397 | 1 | 1 |
| 2023-03-21 | 4 | FORM 4 SUBMISSION | 0001209191-23-020280 | 8919 | ||||||
| 2023-03-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-019611 | 8888 | ||||||
| 2023-03-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-018409 | 5925 | ||||||
| 2023-03-10 | 8-K | 8-K | 8.01 | 0001193125-23-067568 | 001-40407 | 23723509 | 34 | 150217 | 1 | 1 |
| 2023-03-07 | 4 | FORM 4 SUBMISSION | 0001209191-23-016702 | 5917 | ||||||
| 2023-03-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-015418 | 8500 | ||||||
| 2023-02-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-013159 | 5915 | ||||||
| 2023-02-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-010595 | 5213 | ||||||
| 2023-02-17 | 4/A | FORM 4/A SUBMISSION | 0001209191-23-010583 | 5217 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010554 | 5455 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010542 | 5450 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010523 | 5443 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010510 | 5439 | ||||||
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010491 | 5449 | ||||||
| 2023-02-16 | SC 13D/A | SC 13D/A | 0001193125-23-041133 | 005-92556 | 23639002 | 34 | 130845 | |||
| 2023-02-16 | SC 13G | formsc13g.htm | 0001493152-23-005323 | 005-92556 | 23638534 | 34 | 104879 | |||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0001209191-23-009873 | 5926 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021805 | 005-92556 | 23630727 | 34 | 78383 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020723 | 005-92556 | 23622658 | 34 | 137928 | |||
| 2023-02-14 | SC 13D/A | SC 13D/A | 0001104659-23-020136 | 005-92556 | 23621398 | 34 | 127958 | |||
| 2023-02-13 | 4 | FORM 4 SUBMISSION | 0001209191-23-008685 | 5540 | ||||||
| 2023-02-10 | SC 13G | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-23-001012 | 005-92556 | 23610133 | 34 | 43679 | |||
| 2023-02-09 | 4 | FORM 4 SUBMISSION | 0001209191-23-008025 | 13135 | ||||||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-002102 | 005-92556 | 23605139 | 34 | 8137 | |||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-004349 | 13948 | ||||||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-004345 | 6953 | ||||||
| 2023-02-08 | 3 | FORM 3 SUBMISSION | 0000899243-23-004342 | 7094 | ||||||
| 2023-02-08 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-014661 | 22048 | ||||||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-007770 | 4962 | ||||||
| 2023-02-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-007769 | 7739 | ||||||
| 2023-02-06 | SC 13D/A | SC 13D/A | 0001104659-23-010752 | 005-92556 | 23587926 | 34 | 128855 | |||
| 2023-02-03 | SC 13G/A | SC 13G/A | 0001104659-23-010691 | 005-92556 | 23587427 | 34 | 60946 | |||
| 2023-02-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-022827 | 001-40407 | 23582031 | 34 | 432264 | 1 | 1 |
| 2023-02-02 | 424B5 | 424B5 | 0001193125-23-022820 | 333-265408 | 23581997 | 33 | 553641 | |||
| 2023-02-01 | 424B5 | 424B5 | 0001193125-23-021537 | 333-265408 | 23576819 | 33 | 557345 | |||
| 2023-02-01 | 8-K | 8-K | 2.02 | 0001193125-23-021527 | 001-40407 | 23576740 | 34 | 150139 | 1 | 1 |
| 2023-01-30 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-018203 | 001-40407 | 23565111 | 34 | 10505262 | 1 | 1 |
| 2023-01-27 | SC 13G/A | SC 13G/A | 0001104659-23-007194 | 005-92556 | 23559577 | 34 | 136892 | |||
| 2023-01-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-000830 | 001-40407 | 23502862 | 34 | 11085972 | 1 | 1 |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | 0001209191-22-061973 | 12706 | ||||||
| 2022-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-061178 | 20317 | ||||||
| 2022-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-060331 | 4772 | ||||||
| 2022-11-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-058095 | 15037 | ||||||
| 2022-11-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-057513 | 10812 | ||||||
| 2022-11-10 | 4 | FORM 4 SUBMISSION | 0001209191-22-056364 | 4772 | ||||||
| 2022-11-09 | 10-Q | 10-Q | 0000950170-22-023932 | 001-40407 | 221373226 | 34 | 10375129 | 1 | 1 | |
| 2022-11-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023518 | 001-40407 | 221370673 | 34 | 389665 | 1 | 1 |
| 2022-10-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-054192 | 24023 | ||||||
| 2022-10-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-052972 | 4772 | ||||||
| 2022-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-052719 | 25582 | ||||||
| 2022-09-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-051002 | 40449 | ||||||
| 2022-09-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-049902 | 12713 | ||||||
| 2022-09-13 | 4/A | FORM 4/A SUBMISSION | 0001209191-22-049685 | 6005 | ||||||
| 2022-09-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-049681 | 18462 | ||||||
| 2022-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-049316 | 14891 | ||||||
| 2022-09-09 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-241970 | 001-40407 | 221236371 | 34 | 205324 | 1 | 1 |
| 2022-09-09 | 424B5 | 424B5 | 0001193125-22-241471 | 333-265408 | 221235067 | 33 | 353334 | |||
| 2022-09-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-049176 | 4774 | ||||||
| 2022-09-06 | 4 | FORM 4 SUBMISSION | 0001209191-22-048746 | 18461 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047172 | 46063 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047170 | 8155 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047167 | 8335 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047164 | 7774 | ||||||
| 2022-08-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-047162 | 8173 | ||||||
| 2022-08-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-029282 | 31591 | ||||||
| 2022-08-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-045806 | 9148 | ||||||
| 2022-08-11 | SC 13D/A | SC 13D/A | 0001193125-22-218676 | 005-92556 | 221156803 | 34 | 227804 | |||
| 2022-08-11 | 3 | FORM 3 SUBMISSION | 0000899243-22-028385 | 20135 | ||||||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016498 | 001-40407 | 221152269 | 34 | 9496639 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016259 | 001-40407 | 221150412 | 34 | 382932 | 1 | 1 |
| 2022-08-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-044412 | 4774 | ||||||
| 2022-07-20 | 4 | FORM 4 SUBMISSION | 0001209191-22-042675 | 21273 | ||||||
| 2022-07-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-042255 | 11172 | ||||||
| 2022-07-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-041771 | 16236 | ||||||
| 2022-06-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-039055 | 11171 | ||||||
| 2022-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-038582 | 17064 | ||||||
| 2022-06-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-037401 | 14162 | ||||||
| 2022-06-14 | 424B5 | 424B5 | 0001193125-22-173117 | 333-265408 | 221012840 | 33 | 170805 | |||
| 2022-06-14 | 424B5 | 424B5 | 0001193125-22-173113 | 333-265408 | 221012828 | 33 | 285645 | |||
| 2022-06-13 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-06-13 16:30:00 | 9999999995-22-001773 | 333-265408 | 221013344 | 33 | 1692 | ||
| 2022-06-09 | UPLOAD | filename1.pdf | 0000000000-22-006332 | 40198 | ||||||
| 2022-06-09 | CORRESP | filename1.htm | 0001193125-22-171047 | 8253 | ||||||
| 2022-06-03 | S-3 | S-3 | 0001193125-22-167319 | 333-265408 | 22994503 | 33 | 1295254 | |||
| 2022-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-033485 | 9315 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032189 | 5601 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032186 | 5609 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032181 | 5624 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032176 | 5592 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032168 | 5629 | ||||||
| 2022-05-26 | 4 | FORM 4 SUBMISSION | 0001209191-22-032159 | 5462 | ||||||
| 2022-05-26 | 8-K | 8-K | 5.07 | 0001193125-22-160307 | 001-40407 | 22965516 | 34 | 154655 | 1 | 1 |
| 2022-05-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-031857 | 5511 | ||||||
| 2022-05-25 | 3 | FORM 3 SUBMISSION | 0001209191-22-031851 | 6896 | ||||||
| 2022-05-16 | 10-Q | 10-Q | 0000950170-22-010094 | 001-40407 | 22929549 | 34 | 8435208 | 1 | 1 | |
| 2022-05-16 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009943 | 001-40407 | 22925484 | 34 | 398327 | 1 | 1 |
| 2022-04-14 | DEFA14A | DEFA14A | 0001140361-22-014570 | 001-40407 | 22827228 | 34 | 820420 | |||
| 2022-04-14 | DEF 14A | DEF14A | 0001140361-22-014566 | 001-40407 | 22827201 | 34 | 2059639 | |||
| 2022-04-12 | 8-K | 8-K | 5.02 | 0001193125-22-102911 | 001-40407 | 22822257 | 34 | 151983 | 1 | 1 |
| 2022-04-07 | SC 13D/A | AMENDMENT NO.1 | 0000905718-22-000551 | 005-92556 | 22814348 | 34 | 43565 | |||
| 2022-04-05 | SC 13D/A | SC 13D/A | 0001193125-22-095610 | 005-92556 | 22805204 | 34 | 84781 | |||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-013598 | 9130 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-013596 | 5531 | ||||||
| 2022-03-28 | S-8 | S-8 | 0001193125-22-086751 | 333-263899 | 22775951 | 33 | 79828 | |||
| 2022-03-28 | 10-K | 10-K | 0000950170-22-004701 | 001-40407 | 22772751 | 34 | 13130702 | 1 | 1 | |
| 2022-03-24 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-004476 | 001-40407 | 22764698 | 34 | 419703 | 1 | 1 |
| 2022-02-24 | SC 13G | VERA THERAPEUTICS, INC. | 0001104659-22-026621 | 005-92556 | 22671566 | 34 | 75947 | |||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011224 | 5448 | ||||||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011222 | 5437 | ||||||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011220 | 5438 | ||||||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011215 | 5441 | ||||||
| 2022-02-18 | 4 | FORM 4 SUBMISSION | 0001209191-22-011212 | 5450 | ||||||
| 2022-02-14 | 4 | FORM 4 | 0001104659-22-023301 | 10386 | ||||||
| 2022-02-14 | SC 13G/A | VERA THERAPEUTICS, INC. | 0001104659-22-021373 | 005-92556 | 22624907 | 34 | 139190 | |||
| 2022-02-11 | 424B4 | 424B4 | 0001193125-22-037414 | 333-262569 | 22622776 | 33 | 7295034 | |||
| 2022-02-11 | SC 13G | SCHEDULE 13G | 0001104659-22-020616 | 005-92556 | 22622155 | 34 | 65997 | |||
| 2022-02-10 | S-1MEF | S-1MEF | 0001193125-22-033630 | 333-262618 | 22609638 | 33 | 67672 | |||
| 2022-02-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2022-02-09 16:30:00 | 9999999995-22-000386 | 333-262569 | 22609380 | 33 | 1691 |
One latest value per concept from companyfacts (299 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 72.30M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.30B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 6.90M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.63M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 136.72 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 9.13M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 6.99M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 261.7 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-09 | 0001140361-26-014002 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 20.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 11.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AccretionExpenseIncludingAssetRetirementObligations | Accretion Expense, Including Asset Retirement Obligations | USD | 145,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 35.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 257,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 5.20M | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-010094 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 1.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -704,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.42B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 15.73M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 44.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 11.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | Assets | Assets | USD | 465.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 441.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 384.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedGain | Debt Securities, Available-for-sale, Unrealized Gain | USD | 810,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | AvailableForSaleDebtSecuritiesGrossUnrealizedLoss | Debt Securities, Available-for-sale, Unrealized Loss | USD | 224,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 328.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 306.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 328.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 55.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 55.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 55.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -299.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 72,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -325.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 1,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 1,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | DebtInstrumentBasisSpreadOnVariableRate1 | Debt Instrument, Basis Spread on Variable Rate | pure | 0.083 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-07 | 0000950170-25-064733 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 75.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.119 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023932 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | -66,000 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0000950170-24-057292 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | -1.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 2.03M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-212143 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 34,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023932 | |
| us-gaap | DeferredFinanceCostsNoncurrentNet | Debt Issuance Costs, Noncurrent, Net | USD | 1.58M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 572,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 400,000 | 2023-02-06 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-062139 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 7.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 172.84M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 10.33M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 572,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 84.62M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 379.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 406,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 30,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 59.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 9.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 916,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 172.27M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 166,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 180.00M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 |
| us-gaap | DepositsAssetsCurrent | Deposits Assets, Current | USD | 57,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | DepreciationAmortizationAndAccretionNet | Depreciation, Amortization and Accretion, Net | USD | -1.47M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0000950170-24-057292 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 3.07M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021335 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -4.51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.71 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-010094 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -4.51 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.214 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.002 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 15.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | EquitySecuritiesFvNi | Equity Securities, FV-NI | USD | 58,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | EquitySecuritiesFvNiGainLoss | Equity Securities, FV-NI, Gain (Loss) | USD | -11,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-094108 |
| us-gaap | EquitySecuritiesFvNiUnrealizedGainLoss | Equity Securities, FV-NI, Unrealized Gain (Loss) | USD | -47,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-010094 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 0 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016498 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | -454,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 1.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 444,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 1.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 1.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 20.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 20.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 2.70M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021335 |
| us-gaap | GainLossOnSaleOfBusiness | Gain (Loss) on Disposition of Business | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 91.53M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | ImpairmentOfInvestments | Other than Temporary Impairment Losses, Investments | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -299.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -299.61M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 17,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 64.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -62.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.16M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -1.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 64,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -166,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 554,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.29M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 1.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -1.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 11.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 3.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IncreaseDecreaseInAssetsHeldForSale | Increase (Decrease) in Assets Held-for-sale | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 7.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -373,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 0 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | -478,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | 1.91M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023932 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 24.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | IntangibleAssetsNetIncludingGoodwill | Intangible Assets, Net (Including Goodwill) | USD | 20.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InterestExpense | Interest Expense | USD | 3.82M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-094108 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 5.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 21,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004117 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 4.95M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 2.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 350,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 7.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 7.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 5.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InventoryWorkInProcess | Inventory, Work in Process, Gross | USD | 929,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 16.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | LeaseCost | Lease, Cost | USD | 761,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 3.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 830,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 254,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 254,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 995,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 966,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 179,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266881 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 577,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceived | Lessor, Operating Lease, Payments to be Received | USD | 500,000 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-05 | 0000950170-25-103022 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths | Lessor, Operating Lease, Payment to be Received, Year One | USD | 1.50M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear | Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year | USD | 491,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedThreeYears | Lessor, Operating Lease, Payment to be Received, Year Three | USD | 1.50M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | LessorOperatingLeasePaymentsToBeReceivedTwoYears | Lessor, Operating Lease, Payment to be Received, Year Two | USD | 1.50M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 | |
| us-gaap | Liabilities | Liabilities | USD | 132.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 465.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 55.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LineOfCreditFacilityRemainingBorrowingCapacity | Line of Credit Facility, Remaining Borrowing Capacity | USD | 45.00M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016498 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 75.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 40.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 40.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 34.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 328.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 328.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 11,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 9.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -3.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -305.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -324.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 9.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | NotesPayable | Notes Payable | USD | 75.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | OperatingCostsAndExpenses | Operating Costs and Expenses | USD | 343.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 237.62M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -333.32M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.26M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 2.47M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 549,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 1.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 1.69M | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 360,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 10.20M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.67M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals | USD | 3.70M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-10 | 0000950170-24-057292 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 10.20M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 1.95M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.82M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.75M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 2.67M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.125 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 2.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | OtherAccruedLiabilitiesCurrentAndNoncurrent | Other Accrued Liabilities | USD | 341,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 6.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | OtherAssetsMiscellaneousNoncurrent | Other Assets, Miscellaneous, Noncurrent | USD | 613,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 3.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | OtherComprehensiveIncomeLossTax | Other Comprehensive Income (Loss), Tax | USD | 29.85M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021335 |
| us-gaap | OtherIncome | Other Income | USD | -1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 3,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | OtherSundryLiabilitiesCurrent | Other Sundry Liabilities, Current | USD | 286,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 | |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 134,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-010094 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 23,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 357.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | PaymentsToAcquireOtherProductiveAssets | Payments to Acquire Other Productive Assets | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 23,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266881 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266881 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266881 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 38.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PrepaidExpenseAndOtherAssetsNoncurrent | Prepaid Expense and Other Assets, Noncurrent | USD | 2.55M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 535,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | PrepaidExpenseCurrentAndNoncurrent | Prepaid Expense | USD | 253,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 536,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 224,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 5.60M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 2.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 9.57M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 400.90M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266881 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 389.77M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 57,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 550,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 813,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-10 | 0001193125-26-342380 | |
| us-gaap | PurchaseCommitmentRemainingMinimumAmountCommitted | Purchase Commitment, Remaining Minimum Amount Committed | USD | 88.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 88.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PurchaseObligationDueInNextTwelveMonths | Purchase Obligation, to be Paid, Year One | USD | 49.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear | Purchase Obligation, to be Paid, Remainder of Fiscal Year | USD | 38.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 187.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 28,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 1.60M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 1.60M | 2022-01-01 | 2023 | Q2 | 10-Q | 2023-08-10 | 0000950170-23-041399 | |
| us-gaap | RestructuringReserveNoncurrent | Restructuring Reserve, Noncurrent | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | RestructuringReserveSettledWithoutCash2 | Restructuring Reserve, Settled without Cash | USD | 136,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.09B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 10.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | SecuredDebt | Secured Debt | USD | 5.00M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-09 | 0000950170-22-023932 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 152.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 44.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.802 | 2023-07-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.876 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.781 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.042 | 2023-07-01 | 2023-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0000950170-24-123239 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.051 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 180,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 63,177 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 5.12 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 15.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 0 | 2020-07-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004117 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares | shares | 2.02M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 1,654 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 8.92M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1.95M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 3.08 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | shares | 220,042 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-07 | 0001193125-26-212143 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 3.01 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.92 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 333.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 11.587 | 2021-05-07 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 113,683 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-06-24 | 0001193125-21-198663 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 139.58M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1.49M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 48.41M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010288 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2.22M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 13,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 1.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 139.34M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-28 | 0000950170-22-004701 | |
| us-gaap | UnamortizedDebtIssuanceExpense | Unamortized Debt Issuance Expense | USD | 123,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-27 | 0000950170-24-036729 | |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | -301,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 2.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 | |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 535,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 63,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-26 | 0001193125-26-077442 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 35.50M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-28 | 0000950170-25-029969 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 10,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-05 | 0000950170-25-103022 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 71.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 24.23M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0000950170-22-010094 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 71.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449826 |